• A Pilot Study to Assess the Impact of a Validated Illustrated Eczema Action Plan on Pediatric Patients
• Antibiotic/Antimicrobial Resistance in Atopic Dermatitis
• Assessment of Parent-Child Comprehension of Pediatric Patch Testing and Barriers to Improvement
• Atopic Dermatitis: An Assessment of Lesional Morphology by Race/Ethnicity
• Barriers to care for pediatric atopic dermatitis patients and the effects on treatment adherence and follow-up: A cross-sectional survey study

• Pediatric Contact Dermatitis Registry Using New Baseline Series for Children
• Post-Market Surveillance of the Safety of Systemic JAK Inhibitors for Dermatologic Diseases in Children
• The Association Between Psoriasis and Bacterial Infection

Wilkie, Hazel, et al. “Treg cell dysfunction and cutaneous exposure to S. aureus underlie eczema in DOCK8 deficiency” The Journal of Allergy and Clinical Immunology (2024).

Croce, Emily, et al. “Lower socioeconomic status may help explain racial disparities in asthma and atopic dermatitis prevalence: A mediation analysis” Journal of Allergy and Clinical Immunology (2023).

Haft, Michael, et al. “Diagnosis and Management of Pediatric Chronic Hand Eczema: The PeDRA CACHES Survey” Paediatric Drugs (2023).

Choragudi, Siri, et al. “Trends in Health Care Utilization Among United States Children With Eczema by Age, Sex, Race, and Hispanic Ethnicity: National Health Interview Survey 2006-2018” Dermatitis (2023).

Eickstaedt, Joshua, et al. “Paradoxical Psoriasiform Eruptions in Children Receiving Tumor Necrosis Factor α Inhibitors” JAMA Dermatology (2023).

Choragudi, Siri and Yosipovitch, Gil. “Trends in the Prevalence of Eczema Among US Children by Age, Sex, Race, and Ethnicity From 1997 to 2018” JAMA Dermatology (2023).

Chen, Henry, et al. “Efficacy of a lay community health worker (promotoras de salud) program to improve adherence to emollients in Spanish-speaking Latin American pediatric patients in the United States with atopic dermatitis: A randomized, controlled, evaluator-blinded study” Pediatric Dermatology (2022).

Croce, Emily, et al. “Validation of remote atopic dermatitis severity assessment with the Eczema Area and Severity Ondex in children using caregiver-provided photos and videos” Pediatric Dermatology (2022).

Croce, Emily, et al. “Caregiver Preferences and Barriers Toward Accessing Pediatric Dermatology Care for Childhood Atopic Dermatitis” Journal of Pediatric Healthcare (2022).

Rustad, Andrea, et al. “Incorporating joint pain screening into the pediatric dermatologic examination” Pediatric Dermatology (2021).

Bronckers, Inge, et al. “A Comparison of Psoriasis Severity in Pediatric Patients Treated With Methotrexate vs Biologic Agents” JAMA Dermatology (2020).

Siegfried, Elaine C., et al. “Developing drugs for treatment of atopic dermatitis in children (≥ 3 months to< 18 years of age): Draft guidance for industry.” Pediatric Dermatology 35.3 (2018): 303-322.

Singer, Hannah M., et al. “Texting atopic dermatitis patients to optimize learning and eczema area and severity index scores: A pilot randomized control trial.” Pediatric Dermatology 35.4 (2018): 453-457.

Siegfried, Elaine C., et al. “Optimizing Clinical Trials for Atopic Dermatitis in Children.” Journal of Investigative Dermatology 137.6 (2017): 1363-1364.

Bronckers, Inge MGJ, et al. “Safety of systemic agents for the treatment of pediatric psoriasis.” JAMA Dermatology 153.11 (2017): 1147-1157.

Osier, Emily, et al. “Pediatric Psoriasis Comorbidity Screening Guidelines.” JAMA Dermatology 153.7 (2017): 698-704.

Totri, Christine R., et al. “Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: The PeDRA TREAT survey.” Journal of the American Academy of Dermatology 76.2 (2017): 281-285.

Resources for Researchers

AD & Psoriasis Virtual Education

Pediatric Psoriasis Comorbidity Screening Guidelines

Joint Screening Video

The Rapid Joint Examination Technique (R-JET) is a screening examination for arthritis that can be incorporated into the routine dermatological examination when patients complain of joint discomfort, especially those with skin disorders that are known to be associated with arthritis.